Kura Oncology, Inc. (KURA)

Last Closing Price: 9.47 (2026-04-21)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Kura Oncology, Inc. (KURA) had Net Income of $-81.00M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$17.34M
Net Income
$-81.00M
--
$17.34M
$103.60M
$-86.27M
$5.34M
$-80.93M
$-80.93M
$-81.00M
$-81.00M
$-81.00M
$-81.00M
$-86.27M
$-87.25M
87.68M
87.68M
$-0.92
$-0.92
Balance Sheet Financials
$708.66M
$7.86M
$29.70M
$738.36M
$116.97M
$9.71M
$447.25M
$564.23M
$174.13M
$174.13M
$174.13M
87.86M
Cash Flow Statement Financials
$-64.06M
$-13.10M
$1.79M
$224.46M
$149.10M
$-75.36M
$37.11M
--
--
Fundamental Metrics & Ratios
6.06
--
--
0.05
0.06
99.67%
-497.62%
-497.62%
--
-466.82%
-467.23%
$-70.70M
--
--
--
0.02
--
1.97
45.71
-46.52%
-46.52%
-10.97%
-44.06%
$1.98
$-0.81
$-0.73